VOYA Investment Management Portfolio holdings
AUM
$100B
1-Year Return
30.07%
This Quarter Return
-3.47%
1 Year Return
+30.07%
3 Year Return
+120.64%
5 Year Return
+214.86%
10 Year Return
+564.47%
AUM
$48.2B
AUM Growth
-$3.89B
(-7.5%)
Cap. Flow
-$920M
Cap. Flow
% of AUM
-1.91%
Top 10 Holdings %
Top 10 Hldgs %
23.52%
Holding
2,818
New
45
Increased
1,339
Reduced
1,028
Closed
167
Top Buys
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$269M |
| 2 |
Boston Scientific
BSX
|
$238M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$188M |
| 4 |
Walmart
WMT
|
$147M |
| 5 |
Microsoft
MSFT
|
$139M |
Top Sells
| 1 |
Marvell Technology
MRVL
|
$487M |
| 2 |
Adobe
ADBE
|
$366M |
| 3 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
$295M |
| 4 |
Darden Restaurants
DRI
|
$195M |
| 5 |
Philip Morris
PM
|
$191M |
Sector Composition
| 1 | Technology | 27.13% |
| 2 | Healthcare | 13.51% |
| 3 | Consumer Discretionary | 13.19% |
| 4 | Financials | 9.87% |
| 5 | Industrials | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TCS
2501
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $110K | ﹤0.01% |
901
+79
| +10% | +$9.65K |
|
|
LUNA
2502
DELISTED
Luna Innovations Incorporated
LUNA
| $110K | ﹤0.01% |
14,286
+1,689
| +13% | +$13K |
|
2503
Caesarstone
CSTE
$48M
| $109K | ﹤0.01% |
+10,356
| New | +$109K |
|
|
KRON
2504
DELISTED
Kronos Bio
KRON
| $109K | ﹤0.01% |
15,094
| – | – |
|
|
STR
2505
DELISTED
Sitio Royalties
STR
| $109K | ﹤0.01% |
4,031
+573
| +17% | +$15.5K |
|
2506
Oramed Pharmaceuticals
ORMP
$91M
| $108K | ﹤0.01% |
12,508
+1,069
| +9% | +$9.23K |
|
2507
Standard BioTools
LAB
$493M
| $107K | ﹤0.01% |
29,813
| – | – |
|
2508
Noodles & Co
NDLS
$32M
| $107K | ﹤0.01% |
17,930
+1,342
| +8% | +$8.01K |
|
2509
Mersana Therapeutics
MRSN
$35.5M
| $105K | ﹤0.01% |
1,053
| – | – |
|
2510
HF Foods Group
HFFG
$175M
| $103K | ﹤0.01% |
15,527
| – | – |
|
|
CAMP
2511
DELISTED
CalAmp Corp.
CAMP
| $103K | ﹤0.01% |
610
| – | – |
|
2512
Kodiak Sciences
KOD
$452M
| $102K | ﹤0.01% |
13,226
-15,799
| -54% | -$122K |
|
|
RUBY
2513
DELISTED
Rubius Therapeutics, Inc
RUBY
| $100K | ﹤0.01% |
18,095
| – | – |
|
|
EPZM
2514
DELISTED
Epizyme, Inc
EPZM
| $100K | ﹤0.01% |
87,293
+51,891
| +147% | +$59.4K |
|
2515
Teekay
TK
$703M
| $98K | ﹤0.01% |
30,904
+3,676
| +14% | +$11.7K |
|
2516
Verastem
VSTM
$650M
| $97K | ﹤0.01% |
5,711
-547
| -9% | -$9.29K |
|
2517
Apyx Medical
APYX
$77.5M
| $95K | ﹤0.01% |
14,510
+2,266
| +19% | +$14.8K |
|
2518
Ribbon Communications
RBBN
$737M
| $95K | ﹤0.01% |
30,736
-26,897
| -47% | -$83.1K |
|
2519
VistaGen Therapeutics
VTGN
$111M
| $93K | ﹤0.01% |
2,504
| – | – |
|
2520
Arbutus Biopharma
ABUS
$769M
| $92K | ﹤0.01% |
30,937
| – | – |
|
|
CBAY
2521
DELISTED
Cymabay Therapeutics
CBAY
| $92K | ﹤0.01% |
29,653
| – | – |
|
2522
American Superconductor
AMSC
$2.19B
| $91K | ﹤0.01% |
11,993
+1,557
| +15% | +$11.8K |
|
2523
Akebia Therapeutics
AKBA
$801M
| $90K | ﹤0.01% |
125,179
+26
| +0% | +$19 |
|
2524
Acacia Research
ACTG
$322M
| $89K | ﹤0.01% |
19,741
| – | – |
|
2525
Ceco Environmental
CECO
$1.72B
| $89K | ﹤0.01% |
16,260
+2,041
| +14% | +$11.2K |
|